Keynote Speaker Dr. Frank Provenzano, PhD.
Translational Neuroimaging and Machine Learning:
Potential for Drug Development
Dr. Frank Provenzano, PhD. is an Assistant Professor of the Neurological Sciences in the Taub Institute for research on Alzheimer’s disease and the Aging Brain. His work focuses on using high-resolution and readily available structural neuroimaging to examine functional deficits in various diseases in the neurological and psychiatric domain. He develops and tests tools to help understand neurobiology, potential therapeutic efficacy and disease spread in diseases such as Alzheimer’s, those at clinical high risk of psychosis and epilepsy, among others. He received his BS, MS, PhD and post-doctoral training all at Columbia and holds several patents.
Presenting company: Biotia
Biotia, Inc. is a Cornell Tech-launched company, whose test BiotiaDX, leverages artificial intelligence (AI) and next-generation sequencing (NGS) of DNA for rapid precision diagnosis of infectious diseases. BiotiaDX has the potential to significantly improve the ability of clinicians to diagnose and treat patients in a timely fashion, resulting in improved outcomes, reduced mortality, and decreased length of stay.
Presenting company: Enzychem Lifesciences
Enzychem Lifesciences, Corp. (KOSDAQ:183490) is a global biopharmaceutical company based in Seoul, Korea, that is is developing EC-18, an immune modulator that is in development in oncology, anti-inflammatory diseases and NASH. The compound is currently in three clinical trials: Phase 2 studies in Chemotherapy Induced Neutropenia (CIN), Chemoradiation Induced Oral Mucositis (CRIOM), and Acute Radiation Syndrome (ARS). For more information on Enzychem Lifesciences, visit http://www.enzychem.com/
Click here to RSVP
If you have already RSVP’d please do not resend. If you cannot make it as we have had a strong response, please let us know if you cannot attend.
At the SUNY Global Center, we will be able to have posters for presentation about advances that are occurring in our community. If you, your company has a poster relating to research or drug development, please submit to Meeting@NYCMEDTECH.com for consideration. Space is limited.
We want to thank KOTRA (Korea Trade-Investment Promotion Agency) for working with NYCMedtech for letting our forum know more about developments and companies related to Korea for this upcoming Medtech program. Our program book will be featuring many companies that are involved in various aspects of medical technology and research.
Everyone have a great safe and successful summer- see you in September. If you have any companies that have that special something, we are starting to put the fall/winter schedule and always interested in seeing what is new and exciting.
We look forward to seeing you on the evening of September 12th!
Please be aware that security is at a high level, and you will not be able to enter the building without being on the NYC MedTech security list. No admittance will be allowed without confirmation and will be at the offices of SUNY Global Center 116 East 55th Street, New York, NY 10022.